Table 1 Patient characteristic variables for study population.
Patient characteristic (n = 46) | Value | |
|---|---|---|
Gender n (%) | Female | 27 (58.7) |
Male | 19 (41.3) | |
Age (years) | Median (IQR) | 62 (23) |
Weight (kg) | 68.0 (17.1) | |
BMI (kg/m2) | 24.4 (6.0) | |
Cancer type n (%) | Breast | 8 (17.4) |
Colorectal | 8 (17.4) | |
Cervical | 6 (13.0) | |
Lung | 5 (10.9) | |
Mesothelioma | 4 (8.7) | |
Endometrial | 3 (6.5) | |
Pancreatic | 3 (6.5) | |
Prostate | 2 (4.3) | |
Multiple myeloma | 2 (4.3) | |
Gallbladder, bladder, liver, periauricular squamous cell carcinoma, skin cancer | 1 (2.2) | |
Methadone daily dose (mg) | Median (IQR) | 11.3 (13.9) |
Pain score (Scale 0–10) | 3.9 (3.2) | |
Genotype frequency | n (%) | A/A: 34 (73.9) A/G: 11 (23.9) G/G: 1 (2.2) |
Allele frequency | A: 0.859 G: 0.141 | |
